Recent studies have indicated the involvement of another RNA-binding protein, splicing factor proline and glutamine rich (SFPQ), in ALS pathology (Ishigaki et al., 2017; Lee et al., 2015; Luisier et al., 2018). Here, SFPQ is linked to amyotrophic lateral sclerosis.